during tumour progression (Choy et al., 1990; Koretz et al., 1991; Stallmach et al., 1992; Nigam et al., 1993; Lindmark et al., 1993) . A systematic study of integrin expression in normal colon, adenomas and carcinomas within the same patients has shown progressive loss of expression of 013, (which also recognises laminin and collagen) and a5#1, (which recognises fibronectin only) in the transition from adenomas to carcinomas (Pignatelli et al., 1990; Stallmach et al., 1992) . In one report 75% of colorectal carcinomas were found to be completely negative for expression of the major VLA fibronectin receptor, CX5#I (Stallmach et al., 1992) .
The other subfamily of integrins, designated cxv, is so named because the cxv subunit is capable of associating with multiple 13 subunits, including 1,, 3 PI, ,P6 and #38 in various cell lines, but the primary functional role of this subfamily in cancer progression is still unclear (Cheresh et al., 1989; Bodary and McLean, 1990; Vogel et al., 1990;  Orlando and Cheresh, 1991; Wayner et al., 1991; Moyle et al., 1991; Busk et al., 1992) . Of these receptors, av1,, a003 and avB6 and perhaps (Xv#5 are capable of binding fibronectin (Hynes, 1992;  Zhang Charo et al., 1990; Cheng et al., 1991; Busk et al., 1992; Weinacker et al., 1994 (Seftor et al., 1992) . In contrast, the 13 subunit has either not been identified at all in normal and malignant epithelium (Stallmach et al., 1992) or found to be weakly expressed in a minority of tissue specimens (Nigam et al., 1993) . On the other hand weak expression of a, has been reported for the majority of normal mucosal specimens and half of the tumours in one series of patients (Nigam et al., 1993) .
It has been suggested that expression of fibronectin receptors and the assembly of fibronectin matrix is closely associated with a tumorigenic phenotype (Ruoslahti, 1991) . For example, in hepatocellular and breast carcinomas a correlation has been established between poorer differentiation of tumours and up-regulation of expression of some extracellular matrix molecules including fibronectin (Jaskiewicz et al., 1993) . These matrix changes have been observed at the interface between tumour and invaded tissues, suggesting a role for these matrix molecules in invasive and growth-stimulatory events. Indeed, we have previously reported that fibronectin can stimulate growth of colon cancer cells cultured within three-dimensional collagen matrices (Agrez, 1989) . These findings are consistent with the recent proposal that the major fibronectin-binding integrin of the f13 subfamily, ac,1,, functions as a negative growth regulator when not bound to its ligand, whereas when the receptor is occupied the negative signal is relieved and/or a positive growth signal is generated (Juliano and Varner, 1993) . Moreover, recent data from our laboratory have shown that one member of the oe, subfamily that binds fibronectin, a,,6, also enhances growth of colon cancer cells in vitro and in vivo . 4 gM iodoacetamide and 50 jug ml-' soybean trypsin inhibitor) for 1 h on ice. The lysates were centrifuged at 10 000 g for 10 min, then precleared with RAM (rabbit anti-mouse immunoglobulin) coupled to Sepharose 4B beads for 2 h. Immunoprecipitations were carried out using antibodies directly coupled to Sepharose 4B and analysed by sodium dodecyl sulphate -polyacrylamide gel electrophoresis (SDS-PAGE) (7.5% gel) and autoradiography as described previously (Bates et al., 1991) .
Immunoblotting Cell lysates were immunoprecipitated essentially as described above, however, protein-A coupledSepharose 4B beads were used with the polyclonal anti-VNR and anti-/,3 antibodies. Immunoprecipitates were subjected to non-reducing 7.5% SDS-PAGE, then electrophoretically transferred to nitrocellulose membrane. The membrane was probed with the anti-/,3 MAb QE.2E5, and developed using an HRP-conjugated goat anti-mouse secondary (Bio-Rad, Hercules, CA, USA), followed by enhanced chemiluminescence (ECL) detection (DuPont NEN, Boston, MA, USA).
Results
Immunostaining offresh tissue specimens Initially, tissue sections were prepared from three primary colorectal malignancies and tested for the distribution of Ov and P3 using the MAbs 13C2 and SZ21 respectively. islands, and in none of the sections was P3 expressed on tumour cells (Figure lb) .
A further 12 primary tumours were stained with MAb E7P6 against the /6 integrin subunit (fibronectin and tenascin receptor). 6 was identified in 6 of these 12 specimens. In each tumour, patchy expression was restricted to the epithelial component and in some cases, expression of /6 was most prominent within malignant cells located at the advancing edges of tumour cell islands (Figure ic) subunit (see Table I ).
Although /3I was expressed on the surface of all five cell lines (see Table I ), expression of ac was restricted to three lines, COLO 205, LIM 1215 and SW480 as shown in Figure   3 . In contrast, all cell lines were strongly positive for a3 and on none of the lines was there detectable expression of the a4 subunit (data not shown).
Immunoprecipitation analysis
To confirm the association of av with different /3 subunits and to determine whether this subunit also associated with /31 on (Pignatelli et al., 1990; Stallmach et al., 1992) . The effect of a3 occupancy by fibronectin on tumour cell growth is not known. It has been suggested that a3 has a lower affinity for fibronectin than a5, and in contrast to the diminished expression of a, by rodent fibroblasts consequent upon activation of ras oncogenes, expression of a3fl1 remains unaltered in the transformed cells (Ruoslahti and Giancotti, 1989; Plantefaber and Hynes, 1989) . On the other hand, expression of a5flb the 'classical' fibronectin receptor, is required for deposition of a fibronectin matrix, and ectopic expression of a5A3 by transfection into human colon cancer cells has been associated with a marked reduction in tumorigenicity in nude mice (Plantefaber and Hynes, 1989; Varner et al., 1992) . In contrast, in melanoma cell lines the arginine-glycine-aspartate -containing 120 kDa fibronectin fragment has been shown to stimulate mitogenesis only in those clones expressing a^5l1 (Mortarini et al., 1992) .
Interestingly, three of the five colon cancer cell lines tested in the present study expressed aX suggesting that loss of this receptor in colon cancer may not be a general phenomenon as implied from immunostaining data. The av integrin subfamily is also thought to play an important role in tumour cell growth and invasion for some cell types. For example, loss of af33 expression in melanoma cell variants leads to reduced in vivo tumour growth (FeldingHabermann et al., 1992) . Although we observed abundant a, on malignant colonic epithelium, this did not appear to be associated with P3 (which binds multiple ligands including vitronectin and fibronectin). Instead, strong staining for the P3 integrin was seen in cells resembling fibroblasts and host macrophages immediately subjacent to basement membranes surrounding tumour cell islands, consistent with the essentially stromal distribution of af33 as reported by others (Nigam et al., 1993) . However, FACScan analysis did reveal the presence of f, albeit in low amounts, expressed on the surface of two of the five cell lines (Figure 2 and Table I ). More importantly, all but one of the cell lines expressed the fibronectin-binding 16 subunit, which has been shown to enhance colon cancer cell growth in vitro and in vivo .
It is now recognised that the a, subunit can also associate with PI forming an integrin that is thought to have a lower affinity for fibronectin that a5fl1 (Zhang et al., 1993) . The # subunit at approximately 120 kDa found on immunoprecipitations with anti-a, antibody in three of the cell lines studied, was shown to be #I, and the acfli combination appears to be quite widely distributed (Bates et al., 1991; Bodary and McLean, 1990; Bossy and Reichardt, 1990) . The role of this receptor in colon cancer progression is not known, although in
Chinese hamster ovary cells induced to express avfl1, this receptor binds fibronectin but does not facilitate cell migration on this substrate (Zhang et al., 1993) . It is also possible that receptor co-operativity is required between avfli and ax5/ with respect to fibronectin-mediated growth events. For example, the only cell line previously shown to be stimulated to proliferate within three-dimensional collagen gels in response to exogenous fibronectin is LIM 1215 (Agrez, 1989) , and this is the only line in the present study characterised by expression of both a5,fi and ax,#3 receptors.
In summary, we have shown that in the same colon cancer cell line the av subunit can associate with more than one / subunit, and that the /3 subunits associated with av differ between different cell lines. Moreover, it is now clear that Oc06 is a major fibronectin-binding receptor in colorectal cancer. The present study suggests that discrepancy may exist in expression of fibronectin-binding integrins between tumour tissues and established cell lines. Such differences may reflect the masking of different epitopes on integrin receptors by tissue fixation techniques on the one hand, or alternatively, selective pressures associated with the establishment of continuous cell lines. Whatever the reason, the effects of multiple receptors for a given ligand such as fibronectin are likely to be complex, and determined by such factors as availability of cell-binding sites on fibronectin, the relative affinities of fibronectin receptors for their ligand, and differing effects of fragments of fibronectin compared with the intact ligand (Damsky and Werb, 1992) .
